Advances in prevention of contrast-induced nephropathy after coronary angiography or intervention

Meijuan HU,Lei WANG,Jianbin GONG,Gaoliang YAN,Chengchun TANG
DOI: https://doi.org/10.12122/j.issn.1674-4500.2019.04.10
2019-01-01
Abstract:With the application of coronary angiography or intervention in the diagnosis, evaluation and treatment of coronary heart diseases, the incidence of contrast induced nephropathy is increasing. The contrast induced nephropathy are reversible in most patients, but it will increase the incidence of renal and cardiovascular adverse events. Therefore, how to effectively prevent and reduce the incidence of contrast induced acute kidney injury and reduce the incidence of adverse events in high-risk patients has become the focus of the current researches. According to the recommendations for the prevention and treatment of contrast nephropathy in the 2018 guidelines of the European Heart Association, this paper reviewed and summarized the current research progress in the prevention and treatment of the contrast induced nephropathy.
What problem does this paper attempt to address?